Welcome to our dedicated page for Enovix SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enovix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enovix's regulatory disclosures and financial reporting.
Enovix Corp (ENVX) reported that its Chief Legal Officer, Arthi Chakravarthy, had 936 shares of common stock withheld on September 8, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units. After this tax-withholding disposition, Chakravarthy directly holds 589,103 shares of Enovix common stock.
This post-transaction position includes 345,628 shares issuable upon future RSU vesting and settlement, 10,393 vested PRSUs expected to be released in March 2027, and a further 58,500 PRSUs scheduled for release in April 2027 and April 2028. No Rule 10b5-1 trading plan is reported for this transaction.
Enovix Corp (ENVX) reported that Interim CEO Ryan A. Benton received a grant of 19,060 shares of common stock on August 28, 2026, issued upon receipt of a fully vested restricted stock unit (RSU) award representing his bonus for the quarter ended July 5, 2026. On the same date, 10,093 shares of common stock were withheld at $3.36 per share to satisfy related tax withholding obligations from RSU vesting. Following these transactions, Benton’s holdings include 789,817 shares issuable upon future vesting and settlement of RSUs.
Enovix Corp (ENVX) reported that Chief Accounting Officer Kristina Truong received a fully vested award of 12,512 shares of common stock on August 28, 2026, as settlement of RSUs earned for the quarter ended July 5, 2026. On the same date, 6,626 shares were withheld at $3.36 per share to satisfy tax withholding obligations. Truong also has 197,114 RSUs and performance RSUs totaling 37,767 shares scheduled for release in March and April 2027 and April 2028.
Enovix Corp (ENVX) reported that Chief Legal Officer Arthi Chakravarthy received an equity compensation award and related tax withholding transactions. On August 28, 2026, Chakravarthy acquired 18,546 shares of common stock at $0.00 per share from a fully vested RSU bonus award for the quarter ended July 5, 2026. On the same date, 9,821 shares of common stock were withheld at $3.36 per share to satisfy tax withholding obligations tied to the RSU vesting. Footnotes also state that Chakravarthy holds substantial unvested RSUs and PRSUs that may settle into additional shares in 2027 and 2028.
For Enovix Corp (ENVX), Chief Legal Officer Arthi Chakravarthy reported a disposition of 2,221 shares of common stock on 2026-08-24. The shares were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units, rather than sold in the open market. Following this tax-withholding transaction, Chakravarthy directly holds 581,314 shares of Enovix common stock, including a substantial number of unvested and performance-based stock units scheduled to settle between 2027 and 2028.
Enovix Corp officer Kristina Truong reported a Form 4 transaction involving company common stock. On 2026-08-13, 1,015 shares of common stock were disposed of at $4.43 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs); this was not an open-market sale. Following this tax-withholding disposition, Truong directly holds 302,881 shares of common stock, which includes 197,114 shares issuable upon future vesting and settlement of RSUs and vested performance RSUs (PRSUs), consisting of 2,489 PRSUs scheduled for release in March 2027 and an aggregate of 35,278 PRSUs, half to be released in April 2027 and the remainder in April 2028.
Enovix Corporation reported a leadership change and related updates. On August 13, 2026, President and Chief Executive Officer Raj Talluri resigned as CEO, president and director to pursue another opportunity; the company states his resignation did not involve any disagreement over operations, policies or practices and that he will assist with an orderly transition.
Effective August 14, 2026, the Board appointed its chairman and largest shareholder T.J. Rodgers as Executive Chairman and named Ryan Benton, the current Chief Financial Officer, as Interim Chief Executive Officer while a search is conducted for a permanent CEO. Rodgers emphasized this is a CEO transition rather than a strategy transition.
Enovix reaffirmed its third quarter 2026 financial guidance previously provided on August 12, 2026 and highlighted technical progress, including achieving 1,000-cycle life on its 100% silicon-anode AI-class smartphone batteries. Management reiterated focus on smartphone qualification programs, scaling AI-1 smart eyewear battery production, and expanding the MX-1 platform for defense and drone applications.
Enovix Corporation reported higher revenue but continued losses for the fiscal quarter and year-to-date ended July 5, 2026. Quarterly revenue rose to $9.0 million from $7.5 million, and year-to-date revenue increased to $16.6 million from $12.6 million, driven mainly by defense and industrial customers. Gross profit was modest at $1.3 million for the quarter.
The company recorded a quarterly net loss of $43.1 million and a year-to-date net loss of $81.3 million, with higher interest expense from $532.8 million of convertible debt contributing to results. Operating expenses remained high, with year-to-date R&D at $51.0 million and SG&A at $39.1 million, though R&D declined versus the prior year period.
Enovix ended the quarter with $552.1 million in cash, cash equivalents, restricted cash, and investments and working capital of $453.6 million, and expects these resources to meet funding needs for at least the next twelve months. Management highlights progress in smartphone qualification, initial smart eyewear shipments under a 50,000-pack order, a growing $183 million drone/defense pipeline, and ongoing efforts to improve manufacturing yields and scale its lithium-ion and silicon-anode battery platforms.
Enovix Corporation reported second quarter 2026 revenue of $9.0 million, up 21% year-over-year and 19% sequentially, marking its fifth consecutive quarter of year-over-year revenue growth. Year-to-date revenue reached $16.6 million, up 32% from the first half of 2025.
GAAP gross margin was 14.4% and non-GAAP gross margin 19.9%, both lower than a year earlier on a shift in product mix, though the company recorded its seventh consecutive quarter of positive gross profit. GAAP net loss per share was $0.20 and non-GAAP net loss per share $0.13 in the quarter.
Enovix ended the quarter with about $552.1 million in cash, cash equivalents, marketable securities, and restricted cash, and year-to-date free cash flow was an outflow of $67.7 million. The drone, defense, and industrial pipeline in South Korea increased 41% to roughly $183 million, while a 50,000-pack smart-eyewear order began shipping. Third quarter 2026 revenue is projected at $9.0–$10.0 million, up approximately 13% to 25% year-over-year.
Enovix Corp reported that Chief Accounting Officer Kristina Truong had 253 shares of common stock withheld on 2026-08-10 to satisfy tax withholding obligations related to vesting restricted stock units. Following this disposition, she holds 303,896 shares directly, including 199,030 RSU-based shares and vested PRSUs scheduled for release between March 2027 and April 2028.